Rituxan is an FDA-approved monoclonal antibody indicated for treating blood cancers, autoimmune diseases, and inflammatory conditions. Credit: luchschenF via Shutterstock.
Joan David Leonhard is a recent Pharm.D graduate with a strong passion for the pharmaceutical industry and a particular interest in pharmaceutical media and communication. Her brief internship experience includes roles in pharmacy where she built strong patient-pharmacist relationships and a pharmaceutical media internship where she actively contributed to drug information articles, blog posts, social media engagement, and various media projects.
Joan David-Leonhard
Follow on X
Send an email
